Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Macroeconomic Indicators
4.5 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Drug Device Combination Market, by Product
6.1 Introduction
6.2 Catheter
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.1 Antimicrobial catheter
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.2 Urological catheters
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.3 Cardiovascular catheters
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.4 Oximetry catheters
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.5 Thermodilution catheters
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.6 Wound drainage catheter
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.7 Others
6.3 Advanced Wound Care Products
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.1 Antibiotic wound care
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.2 Bone Graft Substitutes
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.2.1 Ceramic based bone graft substitute
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.2.2 Allograft based bone graft substitutes
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.2.3 Cell based bone graft substitutes
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.2.4 others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.3 Antibiotic Bone Cements
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.4 Drug Eluting Stents
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.5 Photodynamic Therapy
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3.6 Others
Chapter 7. Global Drug Device Combination Market, by Application
7.1 Introduction
7.2 Coronary angioplasty
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.2.1 Tachycardia management
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.2.2 Non-Cardiovascular Treatments
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.2.3 Peripheral arterial disease (PAD)
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3 Bone Treatment
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.4 Antimicrobial Applications
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.5 Wound Care
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.6 Ophthalmic Treatment
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.7 Other
Chapter 8. Global Drug Device Combination Market, by End User
8.1 Introduction
8.2 Hospitals & Clinics
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3 Ambulatory Centres
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4 Academic & Research Organization
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 9. Global Drug Device Combination Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 3M
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 AlloSource
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Biomet Orthopedics, Inc.
11.4.1 Company Overview
11.4.2 Technologys/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Biometrix Medical
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Biotronik
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Boston Scientific Corporation
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 C.R. BARD, Inc.
11.8.1 Overview
11.8.2 Product/ Technology Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Cook Critical Care, Inc.
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Covidien Ltd
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Smith & Nephew Plc
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 St. Jude Medical Inc
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Stryker Corporation
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Wright Medical Group, Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Zimmer Holding, Inc.
11.15.1 Overview
11.15.2 Product Overview
11.15.3 Financials
11.15.4 Key Developments
11.15.5 SWOT Analysis
11.16 OtherS
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Global Drug Device Combination Market
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Drug Device Combination Market Synopsis, 2023-2030
Table 2 Global Drug Device Combination Market Estimates and Forecast, 2023-2030 (USD Million)
Table 3 Global Drug Device Combination Market, by Region, 2023-2030 (USD Million)
Table 4 Global Drug Device Combination Market, by Product, 2023-2030 (USD Million)
Table 5 Global Drug Device Combination Market, by Application, 2023-2030 (USD Million)
Table 6 Global Drug Device Combination Market, End User, 2023-2030 (USD Million)
Table 7 North America: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 8 North America: Drug Device Combination, by Application, 2023-2030 (USD Million)
Table 9 North America: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 10 US: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 11 US: Drug Device Combination , by Application, 2023-2030 (USD Million)
Table 12 US: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 13 Canada: Drug Device Combination,by Product, 2023-2030 (USD Million)
Table 14 Canada: Drug Device Combination, by Application, 2023-2030 (USD Million)
Table 15 Canada: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 16 South America: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 17 South America: Drug Device Combination, by Application, 2023-2030 (USD Million)
Table 18 South America: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 19 Europe: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 20 Europe: Drug Device Combination, by Application, 2023-2030 (USD Million)
Table 21 Europe: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 22 Western Europe: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 23 Western Europe: Drug Device Combination, by Application, 2023-2030 (USD Million)
Table 24 Western Europe: Drug Device Combination, by End User, 2023-2030 (USD Million)
Table 25 Eastern Europe: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 26 Eastern Europe: Drug Device Combination , by Application, 2023-2030 (USD Million)
Table 27 Eastern Europe: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 28 Asia-Pacific: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 29 Asia-Pacific: Drug Device Combination , by Application, 2023-2030 (USD Million)
Table 30 Asia-Pacific: Drug Device Combination, End User, 2023-2030 (USD Million)
Table 31 Middle East & Africa: Drug Device Combination, by Product, 2023-2030 (USD Million)
Table 32 Middle East & Africa: Drug Device Combination , by Application, 2023-2030 (USD Million)
Table 33 Middle East & Africa: Drug Device Combination, End User, 2023-2030 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Drug Device Combination Market
Figure 3 Market Dynamics for Global Drug Device Combination Market
Figure 4 Global Drug Device Combination Market Share, by Product, 2023
Figure 5 Global Drug Device Combination Market Share, by Application, 2023
Figure 6 Global Drug Device Combination Market Share, End User, 2023
Figure 7 Global Drug Device Combination Market Share, by Region, 2023
Figure 8 North America: Drug Device Combination Market Share, by Country, 2023
Figure 9 Europe: Drug Device Combination MarketShare, by Country, 2023
Figure 10 Asia-Pacific: Drug Device Combination Market Share, by Country, 2023
Figure 11 Middle East & Africa: Drug Device Combination Market Share, by Region, 2023
Figure 12 Global Drug Device Combination Market: Company Share Analysis, 2023 (%)
Figure 13 3M: Key Financials
Figure 14 3M: Segmental Revenue
Figure 15 3M: Geographical Revenue
Figure 16 Abbott Laboratories: Key Financials
Figure 17 Abbott Laboratories: Segmental Revenue
Figure 18 Abbott Laboratories: Geographical Revenue
Figure 19 AlloSource: Key Financials
Figure 20 AlloSource: Segmental Revenue
Figure 21 AlloSource: Geographical Revenue
Figure 22 Biomet Orthopedics, Inc.: Key Financials
Figure 23 Biomet Orthopedics, Inc.: Segmental Revenue
Figure 24 Biomet Orthopedics, Inc.: Geographical Revenue
Figure 25 Biotronik: Key Financials
Figure 26 Biotronik: Segmental Revenue
Figure 27 Biotronik: Geographical Revenue
Figure 28 Boston Scientific Corporation: Key Financials
Figure 29 Boston Scientific Corporation: Segmental Revenue
Figure 30 Boston Scientific Corporation: Geographical Revenue
Figure 31 C.R. BARD, Inc.: Key Financials
Figure 32 C.R. BARD, Inc.: Segmental Revenue
Figure 33 C.R. BARD, Inc.: Geographical Revenue
Figure 34 Cook Critical Care, Inc.: Key Financials
Figure 35 Cook Critical Care, Inc.: Segmental Revenue
Figure 36 Cook Critical Care, Inc.: Geographical Revenue
Figure 37 Covidien Ltd: Key Financials
Figure 38 Covidien Ltd: Segmental Revenue
Figure 39 Covidien Ltd: Geographical Revenue
Figure 40 Smith & Nephew Plc: Key Financials
Figure 41 Smith & Nephew Plc: Segmental Revenue
Figure 42 Smith & Nephew Plc: Geographical Revenue
Figure 43 St. Jude Medical Inc: Key Financials
Figure 44 St. Jude Medical Inc: Segmental Revenue
Figure 45 St. Jude Medical Inc: Geographical Revenue
Figure 46 Stryker Corporation: Key Financials
Figure 47 Stryker Corporation: Segmental Revenue
Figure 48 Stryker Corporation: Geographical Revenue
Figure 49 Wright Medical Group, Inc.: Key Financials
Figure 50 Wright Medical Group, Inc.: Segmental Revenue
Figure 51 Wright Medical Group, Inc.: Geographical Revenue